NEW YORK (GenomeWeb News) – Nastech Pharmaceutical has obtained a Phase I Small Business Innovation Research grant from the National Institutes of Health to help it develop small-interfering RNA influenza drugs.
The company did not disclose the mount of the grant but Phase I SBIRs typically do not exceed $100,000.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.